Download | < Back |
19 May 2016 | |
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated May 19, 2016 titled 'Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg' | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |